IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

AMRI awarded development and manufacturing contract by UK government

10:06 AM MDT | September 30, 2013 | Deepti Ramesh

Albany Molecular Research Inc. (AMRI; Albany, NY) says that its wholly owned Albany Molecular Research UK (Holywell, UK) subsidiary has been awarded a seven-year contract for the development and manufacture of an active ingredient under clinical evaluation. The contract was awarded by the Defense Science and Technology Laboratory (Salisbury, UK) acting on behalf of the UK secretary of state for defense, the Department of National Defence of Canada (Ottawa), and minister of defense of the Netherlands. AMRI will initially work on the development and scale-up of the...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa